SYGNIS reports half-year results for the period ended 30 June 2013

barbara.lempert •    Significant decrease in total costs and expenses by 44% •    Operating result improved by 65% •    New shareholder loan granted •    US ...

Isotechnika Reports Second Quarter 2013 Financial Results

barbara.lempert Edmonton, Alberta – August 13, 2013 (ISA:TSX):  Isotechnika Pharma Inc. (the “Company”) has released its financial results for the second quarter ...

Soligenix Reports Second Quarter 2013 Results

barbara.lempert Soligenix Reports Second Quarter 2013 Financial Results, and Highlights Recent Accomplishments    Current Cash Resources Total $ 8.1 Million   Princeton, NJ ...

Aeterna Zentaris Reports Second Quarter 2013 Financial and Operating Results

barbara.lempert All amounts are in U.S. dollars (unless otherwise noted) QUEBEC CITY, Aug. 8, 2013 /CNW Telbec/ – Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the “Company”), ...

Healthcare Businesswomen’s Association Announces its 2013 Leadership Conference, The Art and Science of Leadership

barbara.lempert Boston, MA—August 8, 2013—The Healthcare Businesswoman’s Association (HBA) announced today that it anticipates record-breaking attendance at its 2013 Leadership ...

AMRI Announces Second Quarter 2013 Results

barbara.lempert Second Quarter Revenue up 19% at $ 59.3 Million and Adjusted EPS up 100% to $ 0.12 Albany, NY (August 6, 2013) – AMRI (NASDAQ: AMRI) today reported financial and ...

QLT Announces Second Quarter 2013 Results

barbara.lempert VANCOUVER, British Columbia, Aug. 1, 2013 (GLOBE NEWSWIRE) — QLT Inc. (Nasdaq:QLTI) (TSX:QLT) (“QLT” or the “Company”) is a biotechnology ...

HBIO Reports Second Quarter 2013 Results

barbara.lempert HOLLISTON, Mass., Aug. 1, 2013 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools ...

Vical Reports Second Quarter 2013 Financial Results

barbara.lempert Vical Reports Second Quarter 2013 Financial Results, Projects Phase 3 Data Release in August and Establishes Quiet Period SAN DIEGO, Aug. 1, 2013 (GLOBE NEWSWIRE) ...

EpiCept Reports Second Quarter 2013 Operating and Financial Results

barbara.lempert Special August 6 Stockholder Meeting to Approve Final Conditions to Merger with Immune Pharmaceuticals TARRYTOWN, N.Y., Aug. 1, 2013 /PRNewswire/ — EpiCept Corporation ...

Nuvo Research announces 2013 second quarter results

barbara.lempert MISSISSAUGA, ON, July 31, 2013 /CNW/ – Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the ...

The FDA OKs 5 blockbusters in slow start to 2013 drug approvals

John Carroll Few productivity metrics in biopharma measure up to the annual rate of new drug approvals. So now that the FDA has come through with only 13 novel approvals in the first ...
Page 2 of 1012345...10...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS